Low Back Disc Bulge Failure

cultured disc outcome data

It’s always good to report both your successes and failures. I’ve reported on various treatment failures many times before on the blog (here, here, here, and here for example). Talking about both sides of this coin is helpful for patients trying to make treatment decisions.

KB was 39 when he was seen by Dr. Schultz in 2009 to treat a low back disc bulge leading to chronic nerve irritation. Based on his MRI only he was thought to be a good candidate, but based on a hands on exam showing multiple low back and nerve related issues, Dr. Schultz bumped him down to a fair candidate for the Regenexx-C disc procedure. He chose to proceed with the procedure. The patient ultimately saw no change in his condition and ultimately opted for a surgical disc replacement despite the stem cell therapy. We believe in transparency, hence the reason we present our registry data at scientific conferences with our colleagues, publish that data on this site, and publish it (when appropriate) in scientific journals. In fact, I found out about KB’s failure as part of an internal push to get patients who hadn’t responded to our registry questionnaires to provide some data.

Above is all of the collected data on our use of cultured stem cells inside the low back disc to get rid of disc bulges. Almost all of these patients (treated from 2007-2010) couldn’t be managed with simple epidurals and were looking at surgery as their next step. Many did well and pre and post MRIs that showed resolution of their disc bulges (which have been posted on this blog-examples here, here, here). However, the data definitely shows some patients who didn’t respond nor report improvements.

The upshot? Like all medical procedures, our procedures don’t always work. In addition, as we often discuss with patients, because we can only gather partial information from an MRI, a later hands on exam with a physician may improve or reduce your candidacy for these procedures.

Learn More About Regenexx® Procedures
Request a digital booklet and more information to learn about alternatives to orthopedic surgery and the Regenexx patient experience.
We do not sell, or share your information to third party vendors. By submitting the form you agree that you've read and consent to our Privacy Policy.
Chris Centeno, MD is a specialist in regenerative medicine and the new field of Interventional Orthopedics. Centeno pioneered orthopedic stem cell procedures in 2005 and is responsible for a large amount of the published research on stem cell use for orthopedic applications. View Profile

If you have questions or comments about this blog post, please email us at [email protected]

NOTE: This blog post provides general information to help the reader better understand regenerative medicine, musculoskeletal health, and related subjects. All content provided in this blog, website, or any linked materials, including text, graphics, images, patient profiles, outcomes, and information, are not intended and should not be considered or used as a substitute for medical advice, diagnosis, or treatment. Please always consult with a professional and certified healthcare provider to discuss if a treatment is right for you.

TO TOP